nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PPARD—obesity	0.477	0.878	CbGaD
Sulindac—SLC22A6—Cimetidine—obesity	0.04	0.263	CbGbCtD
Sulindac—PTGS2—obesity	0.0351	0.0646	CbGaD
Sulindac—CYP1A2—Phentermine—obesity	0.0327	0.215	CbGbCtD
Sulindac—ALB—obesity	0.0313	0.0576	CbGaD
Sulindac—CYP1A2—Phenylpropanolamine—obesity	0.0312	0.205	CbGbCtD
Sulindac—CYP1A2—Bupropion—obesity	0.0278	0.183	CbGbCtD
Sulindac—CYP1A2—Cimetidine—obesity	0.0204	0.134	CbGbCtD
Sulindac—PTGS2—ovarian follicle—obesity	0.00291	0.0672	CbGeAlD
Sulindac—AKR1B1—islet of Langerhans—obesity	0.00216	0.0499	CbGeAlD
Sulindac—AKR1B1—respiratory system—obesity	0.00204	0.0471	CbGeAlD
Sulindac—AKR1B1—adrenal cortex—obesity	0.00171	0.0396	CbGeAlD
Sulindac—PPARD—islet of Langerhans—obesity	0.0017	0.0393	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—obesity	0.00156	0.0361	CbGeAlD
Sulindac—MAPK3—respiratory system—obesity	0.00148	0.0342	CbGeAlD
Sulindac—AKR1B1—pituitary gland—obesity	0.00138	0.032	CbGeAlD
Sulindac—AKR1B1—adipose tissue—obesity	0.00138	0.0318	CbGeAlD
Sulindac—AKR1B1—digestive system—obesity	0.0013	0.03	CbGeAlD
Sulindac—MAPK3—adrenal cortex—obesity	0.00124	0.0287	CbGeAlD
Sulindac—AKR1B1—adrenal gland—obesity	0.00124	0.0286	CbGeAlD
Sulindac—ALB—gall bladder—obesity	0.00114	0.0263	CbGeAlD
Sulindac—MAPK3—cardiovascular system—obesity	0.00113	0.0262	CbGeAlD
Sulindac—PPARD—adipose tissue—obesity	0.00108	0.025	CbGeAlD
Sulindac—AKR1B1—endocrine gland—obesity	0.00107	0.0248	CbGeAlD
Sulindac—PPARD—digestive system—obesity	0.00102	0.0236	CbGeAlD
Sulindac—MAPK3—pituitary gland—obesity	0.001	0.0232	CbGeAlD
Sulindac—MAPK3—adipose tissue—obesity	0.000999	0.0231	CbGeAlD
Sulindac—PPARD—adrenal gland—obesity	0.000972	0.0225	CbGeAlD
Sulindac—AKR1B1—liver—obesity	0.000967	0.0223	CbGeAlD
Sulindac—MAPK3—digestive system—obesity	0.000941	0.0217	CbGeAlD
Sulindac—MAPK3—adrenal gland—obesity	0.000896	0.0207	CbGeAlD
Sulindac—PPARD—endocrine gland—obesity	0.000843	0.0195	CbGeAlD
Sulindac—MAPK3—endocrine gland—obesity	0.000777	0.018	CbGeAlD
Sulindac—PPARD—liver—obesity	0.00076	0.0176	CbGeAlD
Sulindac—MAPK3—liver—obesity	0.000701	0.0162	CbGeAlD
Sulindac—PTGS2—gall bladder—obesity	0.000621	0.0143	CbGeAlD
Sulindac—CYP1A2—respiratory system—obesity	0.000464	0.0107	CbGeAlD
Sulindac—CYP1A1—respiratory system—obesity	0.000458	0.0106	CbGeAlD
Sulindac—ALB—adrenal gland—obesity	0.000427	0.00987	CbGeAlD
Sulindac—PTGS2—islet of Langerhans—obesity	0.000407	0.0094	CbGeAlD
Sulindac—PTGS1—respiratory system—obesity	0.000402	0.00929	CbGeAlD
Sulindac—PTGS2—respiratory system—obesity	0.000384	0.00888	CbGeAlD
Sulindac—ALB—liver—obesity	0.000334	0.00772	CbGeAlD
Sulindac—PTGS2—adrenal cortex—obesity	0.000323	0.00745	CbGeAlD
Sulindac—CYP1A1—adipose tissue—obesity	0.000309	0.00714	CbGeAlD
Sulindac—PTGS1—cardiovascular system—obesity	0.000308	0.00711	CbGeAlD
Sulindac—CYP1A2—digestive system—obesity	0.000295	0.00681	CbGeAlD
Sulindac—PTGS2—cardiovascular system—obesity	0.000294	0.0068	CbGeAlD
Sulindac—CYP1A1—digestive system—obesity	0.000291	0.00672	CbGeAlD
Sulindac—PTGS1—pituitary gland—obesity	0.000273	0.0063	CbGeAlD
Sulindac—PTGS1—adipose tissue—obesity	0.000272	0.00627	CbGeAlD
Sulindac—PTGS2—pituitary gland—obesity	0.000261	0.00602	CbGeAlD
Sulindac—PTGS2—adipose tissue—obesity	0.00026	0.006	CbGeAlD
Sulindac—PTGS1—digestive system—obesity	0.000256	0.0059	CbGeAlD
Sulindac—PTGS2—digestive system—obesity	0.000244	0.00564	CbGeAlD
Sulindac—CYP1A2—endocrine gland—obesity	0.000244	0.00563	CbGeAlD
Sulindac—PTGS1—adrenal gland—obesity	0.000244	0.00563	CbGeAlD
Sulindac—CYP1A1—endocrine gland—obesity	0.00024	0.00555	CbGeAlD
Sulindac—PTGS2—adrenal gland—obesity	0.000233	0.00538	CbGeAlD
Sulindac—CYP1A2—liver—obesity	0.00022	0.00508	CbGeAlD
Sulindac—CYP1A1—liver—obesity	0.000217	0.00501	CbGeAlD
Sulindac—PTGS1—endocrine gland—obesity	0.000211	0.00488	CbGeAlD
Sulindac—PTGS2—endocrine gland—obesity	0.000202	0.00466	CbGeAlD
Sulindac—Neuropathy peripheral—Bupropion—obesity	0.000197	0.00161	CcSEcCtD
Sulindac—Jaundice—Bupropion—obesity	0.000196	0.0016	CcSEcCtD
Sulindac—Stomatitis—Bupropion—obesity	0.000196	0.0016	CcSEcCtD
Sulindac—Conjunctivitis—Bupropion—obesity	0.000195	0.0016	CcSEcCtD
Sulindac—Tinnitus—Sibutramine—obesity	0.000193	0.00158	CcSEcCtD
Sulindac—Sweating—Bupropion—obesity	0.000193	0.00158	CcSEcCtD
Sulindac—Dizziness—Diethylpropion—obesity	0.000191	0.00156	CcSEcCtD
Sulindac—Epistaxis—Bupropion—obesity	0.000189	0.00155	CcSEcCtD
Sulindac—Alopecia—Orlistat—obesity	0.000189	0.00155	CcSEcCtD
Sulindac—Diarrhoea—Cimetidine—obesity	0.000188	0.00154	CcSEcCtD
Sulindac—Gastroenteritis—Topiramate—obesity	0.000187	0.00153	CcSEcCtD
Sulindac—Vascular purpura—Topiramate—obesity	0.000186	0.00152	CcSEcCtD
Sulindac—Chills—Sibutramine—obesity	0.000186	0.00152	CcSEcCtD
Sulindac—Hepatic failure—Topiramate—obesity	0.000185	0.00151	CcSEcCtD
Sulindac—Arrhythmia—Sibutramine—obesity	0.000185	0.00151	CcSEcCtD
Sulindac—Vomiting—Diethylpropion—obesity	0.000184	0.0015	CcSEcCtD
Sulindac—Flatulence—Orlistat—obesity	0.000183	0.0015	CcSEcCtD
Sulindac—Alopecia—Sibutramine—obesity	0.000183	0.0015	CcSEcCtD
Sulindac—Rash—Diethylpropion—obesity	0.000182	0.00149	CcSEcCtD
Sulindac—Dysgeusia—Orlistat—obesity	0.000182	0.00149	CcSEcCtD
Sulindac—Dermatitis—Diethylpropion—obesity	0.000182	0.00149	CcSEcCtD
Sulindac—PTGS2—liver—obesity	0.000182	0.0042	CbGeAlD
Sulindac—Dizziness—Cimetidine—obesity	0.000182	0.00149	CcSEcCtD
Sulindac—Headache—Diethylpropion—obesity	0.000181	0.00148	CcSEcCtD
Sulindac—Hepatitis—Bupropion—obesity	0.00018	0.00148	CcSEcCtD
Sulindac—Flatulence—Sibutramine—obesity	0.000177	0.00145	CcSEcCtD
Sulindac—Tension—Sibutramine—obesity	0.000177	0.00145	CcSEcCtD
Sulindac—Dysgeusia—Sibutramine—obesity	0.000176	0.00144	CcSEcCtD
Sulindac—Vision blurred—Orlistat—obesity	0.000175	0.00143	CcSEcCtD
Sulindac—Visual disturbance—Topiramate—obesity	0.000175	0.00143	CcSEcCtD
Sulindac—Nervousness—Sibutramine—obesity	0.000175	0.00143	CcSEcCtD
Sulindac—Vomiting—Cimetidine—obesity	0.000175	0.00143	CcSEcCtD
Sulindac—Visual impairment—Bupropion—obesity	0.000174	0.00142	CcSEcCtD
Sulindac—Rash—Cimetidine—obesity	0.000173	0.00142	CcSEcCtD
Sulindac—Dermatitis—Cimetidine—obesity	0.000173	0.00142	CcSEcCtD
Sulindac—Ill-defined disorder—Orlistat—obesity	0.000173	0.00141	CcSEcCtD
Sulindac—Headache—Cimetidine—obesity	0.000172	0.00141	CcSEcCtD
Sulindac—Purpura—Topiramate—obesity	0.000172	0.00141	CcSEcCtD
Sulindac—Nausea—Diethylpropion—obesity	0.000172	0.0014	CcSEcCtD
Sulindac—Erythema multiforme—Bupropion—obesity	0.00017	0.0014	CcSEcCtD
Sulindac—Angioedema—Orlistat—obesity	0.00017	0.00139	CcSEcCtD
Sulindac—Vision blurred—Sibutramine—obesity	0.00017	0.00139	CcSEcCtD
Sulindac—Tinnitus—Bupropion—obesity	0.000168	0.00138	CcSEcCtD
Sulindac—Malaise—Orlistat—obesity	0.000168	0.00137	CcSEcCtD
Sulindac—Flushing—Bupropion—obesity	0.000167	0.00137	CcSEcCtD
Sulindac—Vertigo—Orlistat—obesity	0.000167	0.00137	CcSEcCtD
Sulindac—Ill-defined disorder—Sibutramine—obesity	0.000167	0.00137	CcSEcCtD
Sulindac—Anaemia—Sibutramine—obesity	0.000166	0.00136	CcSEcCtD
Sulindac—Angioedema—Sibutramine—obesity	0.000164	0.00135	CcSEcCtD
Sulindac—Palpitations—Orlistat—obesity	0.000164	0.00135	CcSEcCtD
Sulindac—Nausea—Cimetidine—obesity	0.000163	0.00134	CcSEcCtD
Sulindac—Malaise—Sibutramine—obesity	0.000162	0.00133	CcSEcCtD
Sulindac—Chills—Bupropion—obesity	0.000162	0.00132	CcSEcCtD
Sulindac—Vertigo—Sibutramine—obesity	0.000162	0.00132	CcSEcCtD
Sulindac—Syncope—Sibutramine—obesity	0.000161	0.00132	CcSEcCtD
Sulindac—Convulsion—Orlistat—obesity	0.000161	0.00132	CcSEcCtD
Sulindac—Leukopenia—Sibutramine—obesity	0.000161	0.00132	CcSEcCtD
Sulindac—Arrhythmia—Bupropion—obesity	0.000161	0.00132	CcSEcCtD
Sulindac—Alopecia—Bupropion—obesity	0.000159	0.0013	CcSEcCtD
Sulindac—Palpitations—Sibutramine—obesity	0.000159	0.0013	CcSEcCtD
Sulindac—Chest pain—Orlistat—obesity	0.000158	0.0013	CcSEcCtD
Sulindac—Myalgia—Orlistat—obesity	0.000158	0.0013	CcSEcCtD
Sulindac—Loss of consciousness—Sibutramine—obesity	0.000158	0.00129	CcSEcCtD
Sulindac—Discomfort—Orlistat—obesity	0.000156	0.00128	CcSEcCtD
Sulindac—Convulsion—Sibutramine—obesity	0.000156	0.00128	CcSEcCtD
Sulindac—Hypertension—Sibutramine—obesity	0.000155	0.00127	CcSEcCtD
Sulindac—Flatulence—Bupropion—obesity	0.000155	0.00127	CcSEcCtD
Sulindac—Tension—Bupropion—obesity	0.000154	0.00126	CcSEcCtD
Sulindac—Dysgeusia—Bupropion—obesity	0.000154	0.00126	CcSEcCtD
Sulindac—Myalgia—Sibutramine—obesity	0.000153	0.00125	CcSEcCtD
Sulindac—Chest pain—Sibutramine—obesity	0.000153	0.00125	CcSEcCtD
Sulindac—Arthralgia—Sibutramine—obesity	0.000153	0.00125	CcSEcCtD
Sulindac—Nervousness—Bupropion—obesity	0.000152	0.00125	CcSEcCtD
Sulindac—Anaphylactic shock—Orlistat—obesity	0.000152	0.00124	CcSEcCtD
Sulindac—Oedema—Orlistat—obesity	0.000152	0.00124	CcSEcCtD
Sulindac—Discomfort—Sibutramine—obesity	0.000151	0.00124	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Topiramate—obesity	0.000149	0.00122	CcSEcCtD
Sulindac—Vision blurred—Bupropion—obesity	0.000148	0.00121	CcSEcCtD
Sulindac—Gastritis—Topiramate—obesity	0.000147	0.0012	CcSEcCtD
Sulindac—Oedema—Sibutramine—obesity	0.000147	0.0012	CcSEcCtD
Sulindac—Anaphylactic shock—Sibutramine—obesity	0.000147	0.0012	CcSEcCtD
Sulindac—Hyperhidrosis—Orlistat—obesity	0.000147	0.0012	CcSEcCtD
Sulindac—Muscular weakness—Topiramate—obesity	0.000146	0.0012	CcSEcCtD
Sulindac—Ill-defined disorder—Bupropion—obesity	0.000146	0.00119	CcSEcCtD
Sulindac—Anaemia—Bupropion—obesity	0.000145	0.00119	CcSEcCtD
Sulindac—Shock—Sibutramine—obesity	0.000145	0.00118	CcSEcCtD
Sulindac—Thrombocytopenia—Sibutramine—obesity	0.000144	0.00118	CcSEcCtD
Sulindac—Angioedema—Bupropion—obesity	0.000143	0.00117	CcSEcCtD
Sulindac—Tachycardia—Sibutramine—obesity	0.000143	0.00117	CcSEcCtD
Sulindac—Eosinophilia—Topiramate—obesity	0.000142	0.00116	CcSEcCtD
Sulindac—Hyperhidrosis—Sibutramine—obesity	0.000142	0.00116	CcSEcCtD
Sulindac—Malaise—Bupropion—obesity	0.000142	0.00116	CcSEcCtD
Sulindac—Vertigo—Bupropion—obesity	0.000141	0.00115	CcSEcCtD
Sulindac—Syncope—Bupropion—obesity	0.000141	0.00115	CcSEcCtD
Sulindac—Pancreatitis—Topiramate—obesity	0.000141	0.00115	CcSEcCtD
Sulindac—Leukopenia—Bupropion—obesity	0.00014	0.00115	CcSEcCtD
Sulindac—Anorexia—Sibutramine—obesity	0.00014	0.00115	CcSEcCtD
Sulindac—Sweating increased—Topiramate—obesity	0.00014	0.00114	CcSEcCtD
Sulindac—Palpitations—Bupropion—obesity	0.000139	0.00114	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Orlistat—obesity	0.000138	0.00113	CcSEcCtD
Sulindac—Loss of consciousness—Bupropion—obesity	0.000138	0.00113	CcSEcCtD
Sulindac—Insomnia—Orlistat—obesity	0.000137	0.00112	CcSEcCtD
Sulindac—Hypotension—Sibutramine—obesity	0.000137	0.00112	CcSEcCtD
Sulindac—Paraesthesia—Orlistat—obesity	0.000136	0.00112	CcSEcCtD
Sulindac—Pancytopenia—Topiramate—obesity	0.000136	0.00112	CcSEcCtD
Sulindac—Convulsion—Bupropion—obesity	0.000136	0.00111	CcSEcCtD
Sulindac—Hypertension—Bupropion—obesity	0.000135	0.00111	CcSEcCtD
Sulindac—Dysuria—Topiramate—obesity	0.000134	0.0011	CcSEcCtD
Sulindac—Neutropenia—Topiramate—obesity	0.000134	0.0011	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Sibutramine—obesity	0.000134	0.0011	CcSEcCtD
Sulindac—Dyspepsia—Orlistat—obesity	0.000134	0.00109	CcSEcCtD
Sulindac—Arthralgia—Bupropion—obesity	0.000134	0.00109	CcSEcCtD
Sulindac—Chest pain—Bupropion—obesity	0.000134	0.00109	CcSEcCtD
Sulindac—Myalgia—Bupropion—obesity	0.000134	0.00109	CcSEcCtD
Sulindac—Insomnia—Sibutramine—obesity	0.000133	0.00109	CcSEcCtD
Sulindac—Discomfort—Bupropion—obesity	0.000132	0.00108	CcSEcCtD
Sulindac—Decreased appetite—Orlistat—obesity	0.000132	0.00108	CcSEcCtD
Sulindac—Paraesthesia—Sibutramine—obesity	0.000132	0.00108	CcSEcCtD
Sulindac—Dyspnoea—Sibutramine—obesity	0.000131	0.00107	CcSEcCtD
Sulindac—Photosensitivity reaction—Topiramate—obesity	0.000131	0.00107	CcSEcCtD
Sulindac—Fatigue—Orlistat—obesity	0.000131	0.00107	CcSEcCtD
Sulindac—Somnolence—Sibutramine—obesity	0.000131	0.00107	CcSEcCtD
Sulindac—Hyperglycaemia—Topiramate—obesity	0.000129	0.00106	CcSEcCtD
Sulindac—Dyspepsia—Sibutramine—obesity	0.000129	0.00106	CcSEcCtD
Sulindac—Pneumonia—Topiramate—obesity	0.000129	0.00105	CcSEcCtD
Sulindac—Oedema—Bupropion—obesity	0.000128	0.00105	CcSEcCtD
Sulindac—Anaphylactic shock—Bupropion—obesity	0.000128	0.00105	CcSEcCtD
Sulindac—Decreased appetite—Sibutramine—obesity	0.000128	0.00105	CcSEcCtD
Sulindac—Depression—Topiramate—obesity	0.000128	0.00104	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Topiramate—obesity	0.000127	0.00104	CcSEcCtD
Sulindac—Shock—Bupropion—obesity	0.000126	0.00103	CcSEcCtD
Sulindac—Renal failure—Topiramate—obesity	0.000126	0.00103	CcSEcCtD
Sulindac—Constipation—Sibutramine—obesity	0.000126	0.00103	CcSEcCtD
Sulindac—Neuropathy peripheral—Topiramate—obesity	0.000125	0.00103	CcSEcCtD
Sulindac—Thrombocytopenia—Bupropion—obesity	0.000125	0.00103	CcSEcCtD
Sulindac—Feeling abnormal—Orlistat—obesity	0.000125	0.00102	CcSEcCtD
Sulindac—Tachycardia—Bupropion—obesity	0.000125	0.00102	CcSEcCtD
Sulindac—Stomatitis—Topiramate—obesity	0.000125	0.00102	CcSEcCtD
Sulindac—Conjunctivitis—Topiramate—obesity	0.000124	0.00102	CcSEcCtD
Sulindac—Gastrointestinal pain—Orlistat—obesity	0.000124	0.00102	CcSEcCtD
Sulindac—Hyperhidrosis—Bupropion—obesity	0.000124	0.00101	CcSEcCtD
Sulindac—Anorexia—Bupropion—obesity	0.000122	0.000999	CcSEcCtD
Sulindac—Haematuria—Topiramate—obesity	0.000122	0.000998	CcSEcCtD
Sulindac—Feeling abnormal—Sibutramine—obesity	0.000121	0.000991	CcSEcCtD
Sulindac—Epistaxis—Topiramate—obesity	0.000121	0.000988	CcSEcCtD
Sulindac—Urticaria—Orlistat—obesity	0.000121	0.000987	CcSEcCtD
Sulindac—Gastrointestinal pain—Sibutramine—obesity	0.00012	0.000983	CcSEcCtD
Sulindac—Body temperature increased—Orlistat—obesity	0.00012	0.000982	CcSEcCtD
Sulindac—Hypotension—Bupropion—obesity	0.00012	0.00098	CcSEcCtD
Sulindac—Agranulocytosis—Topiramate—obesity	0.000119	0.000977	CcSEcCtD
Sulindac—Urticaria—Sibutramine—obesity	0.000117	0.000955	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Bupropion—obesity	0.000117	0.000955	CcSEcCtD
Sulindac—Body temperature increased—Sibutramine—obesity	0.000116	0.000951	CcSEcCtD
Sulindac—Insomnia—Bupropion—obesity	0.000116	0.000948	CcSEcCtD
Sulindac—Paraesthesia—Bupropion—obesity	0.000115	0.000941	CcSEcCtD
Sulindac—Hepatitis—Topiramate—obesity	0.000115	0.00094	CcSEcCtD
Sulindac—Dyspnoea—Bupropion—obesity	0.000114	0.000935	CcSEcCtD
Sulindac—Somnolence—Bupropion—obesity	0.000114	0.000932	CcSEcCtD
Sulindac—Dyspepsia—Bupropion—obesity	0.000113	0.000923	CcSEcCtD
Sulindac—Hypersensitivity—Orlistat—obesity	0.000112	0.000915	CcSEcCtD
Sulindac—Decreased appetite—Bupropion—obesity	0.000111	0.000911	CcSEcCtD
Sulindac—Visual impairment—Topiramate—obesity	0.000111	0.000906	CcSEcCtD
Sulindac—Fatigue—Bupropion—obesity	0.00011	0.000904	CcSEcCtD
Sulindac—Constipation—Bupropion—obesity	0.00011	0.000896	CcSEcCtD
Sulindac—Asthenia—Orlistat—obesity	0.000109	0.000891	CcSEcCtD
Sulindac—Erythema multiforme—Topiramate—obesity	0.000109	0.000889	CcSEcCtD
Sulindac—Hypersensitivity—Sibutramine—obesity	0.000108	0.000886	CcSEcCtD
Sulindac—Pruritus—Orlistat—obesity	0.000107	0.000879	CcSEcCtD
Sulindac—Tinnitus—Topiramate—obesity	0.000107	0.000876	CcSEcCtD
Sulindac—Flushing—Topiramate—obesity	0.000107	0.000872	CcSEcCtD
Sulindac—Feeling abnormal—Bupropion—obesity	0.000106	0.000864	CcSEcCtD
Sulindac—Asthenia—Sibutramine—obesity	0.000105	0.000863	CcSEcCtD
Sulindac—Gastrointestinal pain—Bupropion—obesity	0.000105	0.000857	CcSEcCtD
Sulindac—Pruritus—Sibutramine—obesity	0.000104	0.000851	CcSEcCtD
Sulindac—Diarrhoea—Orlistat—obesity	0.000104	0.00085	CcSEcCtD
Sulindac—Chills—Topiramate—obesity	0.000103	0.000843	CcSEcCtD
Sulindac—Urticaria—Bupropion—obesity	0.000102	0.000833	CcSEcCtD
Sulindac—Alopecia—Topiramate—obesity	0.000101	0.000831	CcSEcCtD
Sulindac—Body temperature increased—Bupropion—obesity	0.000101	0.000829	CcSEcCtD
Sulindac—Diarrhoea—Sibutramine—obesity	0.000101	0.000823	CcSEcCtD
Sulindac—Dizziness—Orlistat—obesity	0.0001	0.000822	CcSEcCtD
Sulindac—Flatulence—Topiramate—obesity	9.85e-05	0.000806	CcSEcCtD
Sulindac—Tension—Topiramate—obesity	9.81e-05	0.000803	CcSEcCtD
Sulindac—Dysgeusia—Topiramate—obesity	9.79e-05	0.000801	CcSEcCtD
Sulindac—Dizziness—Sibutramine—obesity	9.71e-05	0.000795	CcSEcCtD
Sulindac—Nervousness—Topiramate—obesity	9.71e-05	0.000795	CcSEcCtD
Sulindac—Vomiting—Orlistat—obesity	9.65e-05	0.00079	CcSEcCtD
Sulindac—Rash—Orlistat—obesity	9.57e-05	0.000783	CcSEcCtD
Sulindac—Dermatitis—Orlistat—obesity	9.56e-05	0.000783	CcSEcCtD
Sulindac—Headache—Orlistat—obesity	9.51e-05	0.000778	CcSEcCtD
Sulindac—Hypersensitivity—Bupropion—obesity	9.44e-05	0.000772	CcSEcCtD
Sulindac—Vision blurred—Topiramate—obesity	9.42e-05	0.000771	CcSEcCtD
Sulindac—Vomiting—Sibutramine—obesity	9.34e-05	0.000765	CcSEcCtD
Sulindac—Ill-defined disorder—Topiramate—obesity	9.28e-05	0.000759	CcSEcCtD
Sulindac—Rash—Sibutramine—obesity	9.26e-05	0.000758	CcSEcCtD
Sulindac—Dermatitis—Sibutramine—obesity	9.25e-05	0.000757	CcSEcCtD
Sulindac—Anaemia—Topiramate—obesity	9.24e-05	0.000756	CcSEcCtD
Sulindac—Headache—Sibutramine—obesity	9.2e-05	0.000753	CcSEcCtD
Sulindac—Asthenia—Bupropion—obesity	9.19e-05	0.000752	CcSEcCtD
Sulindac—Pruritus—Bupropion—obesity	9.06e-05	0.000742	CcSEcCtD
Sulindac—Nausea—Orlistat—obesity	9.02e-05	0.000738	CcSEcCtD
Sulindac—Malaise—Topiramate—obesity	9.02e-05	0.000738	CcSEcCtD
Sulindac—Vertigo—Topiramate—obesity	8.98e-05	0.000735	CcSEcCtD
Sulindac—Syncope—Topiramate—obesity	8.97e-05	0.000734	CcSEcCtD
Sulindac—Leukopenia—Topiramate—obesity	8.95e-05	0.000733	CcSEcCtD
Sulindac—Palpitations—Topiramate—obesity	8.83e-05	0.000723	CcSEcCtD
Sulindac—Loss of consciousness—Topiramate—obesity	8.79e-05	0.000719	CcSEcCtD
Sulindac—Diarrhoea—Bupropion—obesity	8.76e-05	0.000717	CcSEcCtD
Sulindac—Nausea—Sibutramine—obesity	8.73e-05	0.000714	CcSEcCtD
Sulindac—Convulsion—Topiramate—obesity	8.66e-05	0.000709	CcSEcCtD
Sulindac—Hypertension—Topiramate—obesity	8.63e-05	0.000707	CcSEcCtD
Sulindac—Myalgia—Topiramate—obesity	8.51e-05	0.000697	CcSEcCtD
Sulindac—Arthralgia—Topiramate—obesity	8.51e-05	0.000697	CcSEcCtD
Sulindac—Chest pain—Topiramate—obesity	8.51e-05	0.000697	CcSEcCtD
Sulindac—Dizziness—Bupropion—obesity	8.47e-05	0.000693	CcSEcCtD
Sulindac—Discomfort—Topiramate—obesity	8.41e-05	0.000688	CcSEcCtD
Sulindac—Oedema—Topiramate—obesity	8.16e-05	0.000668	CcSEcCtD
Sulindac—Vomiting—Bupropion—obesity	8.14e-05	0.000667	CcSEcCtD
Sulindac—Rash—Bupropion—obesity	8.07e-05	0.000661	CcSEcCtD
Sulindac—Dermatitis—Bupropion—obesity	8.07e-05	0.00066	CcSEcCtD
Sulindac—Shock—Topiramate—obesity	8.03e-05	0.000657	CcSEcCtD
Sulindac—Headache—Bupropion—obesity	8.02e-05	0.000657	CcSEcCtD
Sulindac—Thrombocytopenia—Topiramate—obesity	7.99e-05	0.000654	CcSEcCtD
Sulindac—Tachycardia—Topiramate—obesity	7.96e-05	0.000652	CcSEcCtD
Sulindac—Hyperhidrosis—Topiramate—obesity	7.89e-05	0.000646	CcSEcCtD
Sulindac—Anorexia—Topiramate—obesity	7.78e-05	0.000637	CcSEcCtD
Sulindac—Hypotension—Topiramate—obesity	7.62e-05	0.000624	CcSEcCtD
Sulindac—Nausea—Bupropion—obesity	7.61e-05	0.000623	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Topiramate—obesity	7.43e-05	0.000608	CcSEcCtD
Sulindac—Insomnia—Topiramate—obesity	7.38e-05	0.000604	CcSEcCtD
Sulindac—Paraesthesia—Topiramate—obesity	7.33e-05	0.0006	CcSEcCtD
Sulindac—Dyspnoea—Topiramate—obesity	7.27e-05	0.000595	CcSEcCtD
Sulindac—Somnolence—Topiramate—obesity	7.25e-05	0.000594	CcSEcCtD
Sulindac—Dyspepsia—Topiramate—obesity	7.18e-05	0.000588	CcSEcCtD
Sulindac—Decreased appetite—Topiramate—obesity	7.09e-05	0.000581	CcSEcCtD
Sulindac—Fatigue—Topiramate—obesity	7.03e-05	0.000576	CcSEcCtD
Sulindac—Constipation—Topiramate—obesity	6.98e-05	0.000571	CcSEcCtD
Sulindac—Feeling abnormal—Topiramate—obesity	6.72e-05	0.00055	CcSEcCtD
Sulindac—Gastrointestinal pain—Topiramate—obesity	6.67e-05	0.000546	CcSEcCtD
Sulindac—Urticaria—Topiramate—obesity	6.48e-05	0.000531	CcSEcCtD
Sulindac—Body temperature increased—Topiramate—obesity	6.45e-05	0.000528	CcSEcCtD
Sulindac—Hypersensitivity—Topiramate—obesity	6.01e-05	0.000492	CcSEcCtD
Sulindac—Asthenia—Topiramate—obesity	5.85e-05	0.000479	CcSEcCtD
Sulindac—Pruritus—Topiramate—obesity	5.77e-05	0.000473	CcSEcCtD
Sulindac—Diarrhoea—Topiramate—obesity	5.58e-05	0.000457	CcSEcCtD
Sulindac—Dizziness—Topiramate—obesity	5.4e-05	0.000442	CcSEcCtD
Sulindac—Vomiting—Topiramate—obesity	5.19e-05	0.000425	CcSEcCtD
Sulindac—Rash—Topiramate—obesity	5.14e-05	0.000421	CcSEcCtD
Sulindac—Dermatitis—Topiramate—obesity	5.14e-05	0.000421	CcSEcCtD
Sulindac—Headache—Topiramate—obesity	5.11e-05	0.000418	CcSEcCtD
Sulindac—Nausea—Topiramate—obesity	4.85e-05	0.000397	CcSEcCtD
Sulindac—CYP1A1—Metabolism—GOT1—obesity	2.42e-06	1.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GGT1—obesity	2.42e-06	1.74e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—obesity	2.42e-06	1.74e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2E1—obesity	2.4e-06	1.73e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	2.4e-06	1.73e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NCOA1—obesity	2.38e-06	1.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—obesity	2.38e-06	1.72e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AGT—obesity	2.38e-06	1.72e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NQO1—obesity	2.38e-06	1.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—obesity	2.38e-06	1.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GNAS—obesity	2.36e-06	1.7e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC22A1—obesity	2.36e-06	1.7e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CLOCK—obesity	2.36e-06	1.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—obesity	2.35e-06	1.7e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	2.35e-06	1.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CG—obesity	2.35e-06	1.69e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP19A1—obesity	2.35e-06	1.69e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—STK11—obesity	2.35e-06	1.69e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—obesity	2.33e-06	1.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	2.33e-06	1.68e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.33e-06	1.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	2.33e-06	1.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS1—obesity	2.32e-06	1.67e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOB—obesity	2.31e-06	1.67e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAV1—obesity	2.31e-06	1.67e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOA1—obesity	2.31e-06	1.66e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.31e-06	1.66e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SULT2A1—obesity	2.3e-06	1.66e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GLP1R—obesity	2.3e-06	1.66e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCG—obesity	2.28e-06	1.64e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC2A4—obesity	2.28e-06	1.64e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DPYD—obesity	2.26e-06	1.63e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS2—obesity	2.26e-06	1.63e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYCS—obesity	2.25e-06	1.62e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—POMC—obesity	2.24e-06	1.61e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—obesity	2.22e-06	1.6e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—obesity	2.21e-06	1.59e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—obesity	2.21e-06	1.59e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.21e-06	1.59e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GGT1—obesity	2.21e-06	1.59e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GOT1—obesity	2.21e-06	1.59e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CAV1—obesity	2.19e-06	1.58e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—obesity	2.19e-06	1.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOA1—obesity	2.19e-06	1.58e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—COMT—obesity	2.18e-06	1.57e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PRKAR2B—obesity	2.18e-06	1.57e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NCOA1—obesity	2.17e-06	1.57e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DCN—obesity	2.16e-06	1.56e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GPX1—obesity	2.16e-06	1.55e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GNB3—obesity	2.15e-06	1.55e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARGC1A—obesity	2.15e-06	1.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—obesity	2.15e-06	1.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—obesity	2.15e-06	1.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT2—obesity	2.15e-06	1.55e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—obesity	2.14e-06	1.55e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP19A1—obesity	2.14e-06	1.54e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—STK11—obesity	2.14e-06	1.54e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.12e-06	1.53e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CG—obesity	2.11e-06	1.52e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CPT1A—obesity	2.1e-06	1.52e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—obesity	2.1e-06	1.51e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CD36—obesity	2.1e-06	1.51e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GNAS—obesity	2.1e-06	1.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CD—obesity	2.07e-06	1.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NAMPT—obesity	2.06e-06	1.49e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—BAD—obesity	2.06e-06	1.49e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOB—obesity	2.05e-06	1.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	2.05e-06	1.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LIPC—obesity	2.05e-06	1.48e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCK—obesity	2.05e-06	1.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SERPINE1—obesity	2.04e-06	1.47e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOC3—obesity	2.04e-06	1.47e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—obesity	2.03e-06	1.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	2.02e-06	1.46e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—POMC—obesity	2e-06	1.44e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—obesity	1.99e-06	1.44e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—COMT—obesity	1.99e-06	1.44e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—obesity	1.99e-06	1.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MYC—obesity	1.99e-06	1.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TYK2—obesity	1.99e-06	1.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—obesity	1.99e-06	1.43e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CETP—obesity	1.98e-06	1.42e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS1—obesity	1.97e-06	1.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RHOA—obesity	1.97e-06	1.42e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARGC1A—obesity	1.96e-06	1.42e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GNB3—obesity	1.96e-06	1.42e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—obesity	1.96e-06	1.41e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SDC1—obesity	1.95e-06	1.41e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—obesity	1.95e-06	1.41e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARA—obesity	1.95e-06	1.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—obesity	1.95e-06	1.41e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3R1—obesity	1.95e-06	1.41e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKR1C3—obesity	1.92e-06	1.39e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GPX1—obesity	1.91e-06	1.38e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GNAS—obesity	1.91e-06	1.38e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SCARB1—obesity	1.89e-06	1.36e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AGT—obesity	1.89e-06	1.36e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—obesity	1.89e-06	1.36e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOB—obesity	1.87e-06	1.35e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.87e-06	1.35e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CD36—obesity	1.86e-06	1.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PIK3CA—obesity	1.86e-06	1.34e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—obesity	1.85e-06	1.33e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CD—obesity	1.85e-06	1.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MYC—obesity	1.85e-06	1.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	1.84e-06	1.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—obesity	1.84e-06	1.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SREBF1—obesity	1.84e-06	1.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAV1—obesity	1.84e-06	1.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOA1—obesity	1.83e-06	1.32e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—obesity	1.83e-06	1.32e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—obesity	1.83e-06	1.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT2—obesity	1.83e-06	1.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CB—obesity	1.8e-06	1.3e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MTOR—obesity	1.8e-06	1.3e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT2—obesity	1.79e-06	1.29e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—obesity	1.79e-06	1.29e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—obesity	1.77e-06	1.27e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.76e-06	1.27e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CD—obesity	1.75e-06	1.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.75e-06	1.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—FASN—obesity	1.75e-06	1.26e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3R1—obesity	1.75e-06	1.26e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—obesity	1.75e-06	1.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GPX1—obesity	1.74e-06	1.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—BCHE—obesity	1.74e-06	1.26e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—SERPINE1—obesity	1.74e-06	1.25e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARA—obesity	1.73e-06	1.25e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CD36—obesity	1.7e-06	1.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PIK3CA—obesity	1.7e-06	1.22e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TYK2—obesity	1.69e-06	1.22e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2E1—obesity	1.68e-06	1.21e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AGT—obesity	1.68e-06	1.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—RHOA—obesity	1.67e-06	1.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CG—obesity	1.67e-06	1.2e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NQO1—obesity	1.66e-06	1.2e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3R1—obesity	1.66e-06	1.19e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—obesity	1.66e-06	1.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—obesity	1.65e-06	1.19e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—obesity	1.64e-06	1.18e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAV1—obesity	1.63e-06	1.17e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.63e-06	1.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOA1—obesity	1.63e-06	1.17e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CB—obesity	1.61e-06	1.16e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—obesity	1.61e-06	1.16e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.61e-06	1.16e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—obesity	1.61e-06	1.16e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—obesity	1.6e-06	1.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A4—obesity	1.59e-06	1.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCG—obesity	1.59e-06	1.15e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—POMC—obesity	1.59e-06	1.15e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—obesity	1.58e-06	1.14e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARA—obesity	1.58e-06	1.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYCS—obesity	1.57e-06	1.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PIK3CA—obesity	1.57e-06	1.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—obesity	1.57e-06	1.13e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3CA—obesity	1.56e-06	1.12e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.56e-06	1.12e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GGT1—obesity	1.54e-06	1.11e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GOT1—obesity	1.54e-06	1.11e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CB—obesity	1.53e-06	1.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTOR—obesity	1.53e-06	1.1e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—AGT—obesity	1.53e-06	1.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—obesity	1.52e-06	1.1e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NCOA1—obesity	1.52e-06	1.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—obesity	1.52e-06	1.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—obesity	1.5e-06	1.08e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—obesity	1.5e-06	1.08e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—STK11—obesity	1.5e-06	1.08e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP19A1—obesity	1.5e-06	1.08e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAV1—obesity	1.48e-06	1.07e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CG—obesity	1.48e-06	1.07e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOA1—obesity	1.48e-06	1.07e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CD—obesity	1.47e-06	1.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—obesity	1.45e-06	1.05e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—obesity	1.43e-06	1.03e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.42e-06	1.02e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—POMC—obesity	1.41e-06	1.02e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—obesity	1.4e-06	1.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—COMT—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3R1—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—obesity	1.39e-06	1e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—obesity	1.38e-06	9.94e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARGC1A—obesity	1.37e-06	9.9e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GNB3—obesity	1.37e-06	9.9e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—obesity	1.37e-06	9.85e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CG—obesity	1.35e-06	9.75e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GNAS—obesity	1.34e-06	9.64e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOB—obesity	1.31e-06	9.44e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—obesity	1.31e-06	9.41e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CD—obesity	1.3e-06	9.4e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MYC—obesity	1.29e-06	9.32e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—obesity	1.29e-06	9.3e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—obesity	1.29e-06	9.28e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—POMC—obesity	1.29e-06	9.28e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CB—obesity	1.28e-06	9.23e-06	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—obesity	1.28e-06	9.23e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—obesity	1.28e-06	9.23e-06	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—obesity	1.27e-06	9.17e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—obesity	1.25e-06	9.01e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3R1—obesity	1.23e-06	8.88e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—obesity	1.23e-06	8.88e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GPX1—obesity	1.22e-06	8.79e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CD—obesity	1.19e-06	8.57e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CD36—obesity	1.19e-06	8.56e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—obesity	1.18e-06	8.52e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CB—obesity	1.14e-06	8.19e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—obesity	1.13e-06	8.12e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—obesity	1.13e-06	8.11e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3R1—obesity	1.12e-06	8.09e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—obesity	1.12e-06	8.09e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARA—obesity	1.1e-06	7.96e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—MYC—obesity	1.1e-06	7.92e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CA—obesity	1.1e-06	7.91e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—obesity	1.1e-06	7.9e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AGT—obesity	1.07e-06	7.71e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—obesity	1.05e-06	7.55e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAV1—obesity	1.04e-06	7.48e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CB—obesity	1.04e-06	7.47e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOA1—obesity	1.04e-06	7.47e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—obesity	1.03e-06	7.4e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.92e-07	7.15e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CA—obesity	9.84e-07	7.09e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—obesity	9.72e-07	7.01e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CG—obesity	9.46e-07	6.82e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—PIK3CA—obesity	9.32e-07	6.72e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—obesity	9.13e-07	6.58e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—POMC—obesity	9e-07	6.49e-06	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—obesity	8.97e-07	6.46e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—obesity	8.95e-07	6.45e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CD—obesity	8.32e-07	5.99e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—obesity	8.26e-07	5.95e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—obesity	8.21e-07	5.92e-06	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—obesity	8.04e-07	5.79e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3R1—obesity	7.85e-07	5.66e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—obesity	7.85e-07	5.66e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CA—obesity	7.81e-07	5.63e-06	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—obesity	7.62e-07	5.49e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CB—obesity	7.25e-07	5.22e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—obesity	7.18e-07	5.18e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CA—obesity	6.93e-07	4.99e-06	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—obesity	6.38e-07	4.6e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CA—obesity	6.32e-07	4.55e-06	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—obesity	5.66e-07	4.08e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—obesity	5.16e-07	3.72e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CA—obesity	4.42e-07	3.18e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—obesity	3.61e-07	2.6e-06	CbGpPWpGaD
